CPI and the Association of British HealthTech Industries (ABHI) have announced the Health Technology Regulatory and Innovation Programme, funded by Innovate UK.
CPI is part of the High-Value Manufacturing Catapult. This joint initiative with ABHI will help small and medium-sized HealthTech companies to navigate the HealthTech regulatory processes.
The UK has a vibrant and rapidly-growing HealthTech sector, supplying a variety of products such as:
This £7 million funding program will see many UK small and medium sized enterprises (SME) benefit from funds to help meet their regulatory needs.
Health technologies are highly regulated, with manufacturers needing to meet stringent requirements to sell goods into:
The UK’s regulatory landscape for HealthTech is changing, and manufacturers will need to prepare for a UK sovereign regulatory system. This is because the Medicines and Healthcare Products Regulatory Agency (MHRA)is currently consulting on the future regulation of medical devices and invitro diagnostics in the UK.
Information obtained from the UKRI site.
Do not lose this chance!
If you are UK based and need Regulatory Support, RQMIS´s London office is at the ready to help you to take the opportunity to utilize your grant funding.